Parkinson disease trials in Netherlands

In Netherlands 35 Also abroad 823

35 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease
Where
Amsterdam, 's-Hertogenbosch, Zwolle
Age
40 years to 85 years
People
474 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07781644 · EU 2025-524064-37-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Where
Amsterdam, 's-Hertogenbosch, Zwolle
Age
50 years to 85 years
People
900 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07174310 · EU 2025-522683-32-00
No phaseTaking people
Non-invasive Brain Stimulation for the Treatment of Mild Cognitive Impairment in Parkinson's Disease
Where
Amsterdam
People
20
Run by
Amsterdam UMC
See details and how to joinNCT06399731
No phaseTaking people
STIMPulseControl Ancillary Speech Study
Where
Amsterdam
Age
18 years to 70 years
People
60 worldwide
Run by
Steffen Paschen
See details and how to joinNCT06561919
Phase 2/3Taking people
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Where
Amsterdam, Groningen, Leiden, Nijmegen, 's-Hertogenbosch
Age
40 years to 80 years
People
550 worldwide
Run by
Biohaven Therapeutics Ltd.
See details and how to joinNCT06976268 · EU 2025-521113-13-00
Phase 1Taking people
A study to test the biological properties of RO7568282 and whether it is safe in healthy participants and participants with Parkinson’s disease.
Where
Amsterdam, Groningen, Nijmegen, 's-Hertogenbosch, Zwolle
Age
18 years and over
People
150 worldwide
Run by
F. Hoffmann-La Roche AG
See details and how to join2024-511110-21-00 · EU 2024-511110-21-00
No phaseTaking people
Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseControl
Where
Amsterdam
Age
18 years to 70 years
People
60 worldwide
Run by
University of Kiel
See details and how to joinNCT06498349
Phase 1Taking people
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
Where
Groningen, Nijmegen
Age
30 years to 80 years
People
124 worldwide
Run by
Prevail Therapeutics
See details and how to joinNCT06565195 · EU 2024-513411-27-00
No phaseTaking people
Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
Where
Nijmegen
Age
50 years and over
People
600 worldwide
Run by
Radboud University Medical Center
See details and how to joinNCT06993142
Phase 1Taking people
First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
Where
Leiden
Age
50 years to 80 years
People
46 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT07216066 · EU 2025-521431-37-00
No phaseNot yet taking people in Netherlands
Closed-Loop Therapeutic Refinement Using Local Field Potentials in Parkinson's Disease
Where
Amsterdam, Maastricht
People
30
Run by
HagaZiekenhuis
See details and how to joinNCT07105280
Phase 2Not yet taking people in Netherlands
A Phase 2 study of VQ-101 in participants with Parkinson’s disease and GBA1 mutation
Where
Nijmegen
Age
18 years and over
People
16 worldwide
Run by
Vanqua Bio Inc.
See details and how to join2026-525848-15-00 · EU 2026-525848-15-00
No phaseTaking people
Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
Where
Nijmegen
Age
50 years and over
People
110
Run by
Radboud University Medical Center
See details and how to joinNCT06193252
No phaseTaking people
Research Into the Expression of the csgA-gene and How it Changes in Patients With Parkinson's Disease
Where
Leiden
Age
18 years to 80 years
People
200
Run by
Vertero Therapeutics
See details and how to joinNCT07175922
Phase 2Taking people
A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's Disease
Where
Groningen
Age
40 years and over
People
45
Run by
GEN İlaç ve Sağlık Ürünleri A.Ş.
See details and how to joinNCT07322887 · EU 2025-524674-42-00
No phaseTaking people
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Where
Nijmegen
Age
30 years and over
People
4,500 worldwide
Run by
Michael J. Fox Foundation for Parkinson's Research
See details and how to joinNCT04477785
Phase 1Taking people
Research into the safety of a new agent (NRG5051) in healthy adults and patients with Parkinson's disease or ALS
Where
Leiden
Age
18 years and over
People
118
Run by
Nrg Therapeutics Limited
See details and how to join2025-523872-22-00 · EU 2025-523872-22-00
Phase 3Taking people
Pharmacologically modulating the noradrenergic arousal system to reduce freezing of gait in Parkinson’s disease: a multi-center and multi-modal approach.
Where
Nijmegen
Age
18 years and over
People
20
Run by
Stichting Radboud universitair medisch centrum
See details and how to join2024-516756-18-00 · EU 2024-516756-18-00
Phase 2Taking people
Psilocybin Therapy for Psychological Distress in Palliative Patients
Where
Groningen
Age
18 years and over
People
108 worldwide
Run by
University Medical Center Groningen
See details and how to joinNCT06782724 · EU 2023-510488-36-01
Phase 1Taking people
Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease
Where
Leiden
Age
18 years to 80 years
People
84
Run by
Vertero Therapeutics
See details and how to joinNCT07310264 · EU 2025-523254-14-00
No phaseTaking people
Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease
Where
Amsterdam, Nijmegen
People
84
Run by
Amsterdam UMC, location VUmc
See details and how to joinNCT06416345
Phase 3Taking people
Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal Approach
Where
Nijmegen
Age
18 years and over
People
60
Run by
Radboud University Medical Center
See details and how to joinNCT07316296
Phase 2Taking people
Management of Parkinson's disease if levodopa is broken down prematurely
Where
Nijmegen
Age
18 years and over
People
81
Run by
Stichting Radboud University Medical Center
See details and how to join2024-510629-24-00 · EU 2024-510629-24-00
No phaseTaking people
Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
Where
Amsterdam, Maastricht, The Hague
Age
18 years and over
People
130 worldwide
Run by
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT06909045
Phase 2Not yet taking people in Netherlands
Evaluation of [18F]MC225 to measure P-glycoprotein function in neurodegenerative disease
Where
Groningen
Age
18 years and over
People
30
Run by
Universitair Medisch Centrum Groningen
See details and how to join2024-518865-85-00 · EU 2024-518865-85-00